Transplantation Conditioning
"Transplantation Conditioning" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Preparative treatment of transplant recipient with various conditioning regimens including radiation, immune sera, chemotherapy, and/or immunosuppressive agents, prior to transplantation. Transplantation conditioning is very common before bone marrow transplantation.
| Descriptor ID |
D019172
|
| MeSH Number(s) |
E02.095.465.425.450.800 E05.478.610.800
|
| Concept/Terms |
Transplantation Conditioning- Transplantation Conditioning
- Conditioning, Transplantation
- Conditionings, Transplantation
- Transplantation Conditionings
|
Below are MeSH descriptors whose meaning is more general than "Transplantation Conditioning".
Below are MeSH descriptors whose meaning is more specific than "Transplantation Conditioning".
This graph shows the total number of publications written about "Transplantation Conditioning" by people in this website by year, and whether "Transplantation Conditioning" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 2 | 2 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 4 | 2 | 6 |
| 2003 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 3 | 4 |
| 2006 | 2 | 1 | 3 |
| 2007 | 0 | 5 | 5 |
| 2008 | 7 | 3 | 10 |
| 2009 | 3 | 6 | 9 |
| 2010 | 3 | 3 | 6 |
| 2011 | 1 | 4 | 5 |
| 2012 | 3 | 4 | 7 |
| 2013 | 2 | 2 | 4 |
| 2014 | 6 | 3 | 9 |
| 2015 | 13 | 5 | 18 |
| 2016 | 5 | 0 | 5 |
| 2017 | 9 | 7 | 16 |
| 2018 | 11 | 8 | 19 |
| 2019 | 10 | 3 | 13 |
| 2020 | 3 | 13 | 16 |
| 2021 | 3 | 3 | 6 |
| 2022 | 0 | 10 | 10 |
| 2023 | 0 | 8 | 8 |
| 2024 | 3 | 5 | 8 |
| 2025 | 4 | 2 | 6 |
| 2026 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transplantation Conditioning" by people in Profiles.
-
Phase II Study of Posttransplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After HLA-Mismatched Unrelated Donor Reduced Intensity Transplantation: Results From the ACCESS Trial Expansion Cohort. Am J Hematol. 2026 Nov; 101(11):2827-2835.
-
Pneumococcal colonization in pediatric patients undergoing hematopoietic cell transplantation. Microbiol Spectr. 2026 Jul 07; 14(7):e0400625.
-
Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report. Blood Adv. 2026 Mar 10; 10(5):1783-1798.
-
Long-term Follow-up After Mixed Donor Myeloid Chimerism at 1 Year Post Transplantation for Sickle Cell Disease. Transplant Cell Ther. 2026 Jun; 32(6):709.e1-709.e10.
-
RBC Alloimmunization Impacts Pediatric Sickle Cell Disease Transplant Outcomes and Transfusion Burden: A STAR Registry Report. Am J Hematol. 2026 Apr; 101(4):756-767.
-
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm. Bone Marrow Transplant. 2026 03; 61(3):333-340.
-
Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT. Bone Marrow Transplant. 2026 01; 61(1):36-43.
-
Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy. Transplant Cell Ther. 2025 Oct; 31(10):826.e1-826.e10.
-
Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with highdose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapy. Haematologica. 2025 11 01; 110(11):2635-2646.
-
Fludarabine Plus Myeloablative Dose of Busulfan Regimen Was Associated with High Nonrelapse Mortality in Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Lymphoma: A Propensity Score-Matched Comparison Study with Fludarabine Plus High-Dose Melphalan. Transplant Cell Ther. 2025 Jun; 31(6):382.e1-382.e17.